2016
DOI: 10.1016/j.bbrc.2016.03.117
|View full text |Cite
|
Sign up to set email alerts
|

A novel selective inhibitor to thrombin-induced platelet aggregation purified from the leech Whitmania pigra

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(13 citation statements)
references
References 27 publications
0
12
0
Order By: Relevance
“…Whitmania pigra Whitman, etc. (Feng et al, 2012; Lu M. et al, 2015; Lu Y. et al, 2015; Liu et al, 2016). Xiao et al (2012) identified two PAI-1 inhibitors, tanshinone IIA and cryptotanshinone, from Salvia miltiorrhiza Bge , and inhibition of PAI-1 was considered to be one of the mechanism by which Salvia miltiorrhiza Bge exerts its anticoagulant effect.…”
Section: Discussionmentioning
confidence: 99%
“…Whitmania pigra Whitman, etc. (Feng et al, 2012; Lu M. et al, 2015; Lu Y. et al, 2015; Liu et al, 2016). Xiao et al (2012) identified two PAI-1 inhibitors, tanshinone IIA and cryptotanshinone, from Salvia miltiorrhiza Bge , and inhibition of PAI-1 was considered to be one of the mechanism by which Salvia miltiorrhiza Bge exerts its anticoagulant effect.…”
Section: Discussionmentioning
confidence: 99%
“…Besides, WP-30 is a selective inhibitor to thrombin-induced platelet aggregation rather than other inducers (collagen or U46619) in vitro. 39 AEW had no effect on ADP-induced platelet aggregation in vivo in our study ( Fig. 2E).…”
Section: Discussionmentioning
confidence: 48%
“…38 A novel peptide named WP-30 from W pigra selectively inhibits thrombin-induced platelet aggregation in vitro and synthetic WP-30 attenuates thrombus formation in rats. 39 WP-30 is one kind of peptide in AEW, and it will be hydrolyzed if it is orally administered. Therefore, WP-30 was administered through tail vein to avoid hydrolyzing.…”
Section: Discussionmentioning
confidence: 99%
“…As the most potent agonist of platelet activation, thrombin not only induced platelet aggregation by activating the corresponding receptors, but also promoted the development of early platelet thrombus (Adam, Guillin, & Jandrot‐Perrus, 2003; Liu et al, 2016; Maruyama, Nonaka, & Tanaka, 1993). As shown in Figure 5f, the formation of platelet thrombosis was observed.…”
Section: Resultsmentioning
confidence: 99%